Pharmafile Logo
Pharmafocus logo
Advanced Search
amgen_hq

CytomX scores deal with Amgen worth potential $1.5bn

October 4, 2017
Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

News

Police raid French HQ of Merck KGaA over thyroid drug scandal

October 4, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Levothyrox, Merck KGaA, hyperthyroidism, pharma, pharmaceuticals

Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …

News
cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017
Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …

News
shire_image

Shire takes fight to Allergan over dry-eye drug

October 4, 2017
Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …

News
nih_logo

NIH funds research into infant opioid withdrawal syndrome treatment

October 3, 2017
Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals

As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …

News

Bavarian Nordic seals $539 million vaccine deal

October 3, 2017
Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical

Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …

News

FDA to expedite complex generic approvals to lower drug prices through competition

October 3, 2017
Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical

In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …

News
flu_vaccine

‘Universal flu vaccine’ to be trialed this winter

October 3, 2017
Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …

News
astrazeneca_logo_building

AstraZeneca Chairman wants three-year Brexit transition period

October 3, 2017
Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical

The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …

News

Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma

October 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …

Feature
child_flu

Collaboration brings forward potential broad flu cure

October 2, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical

A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …

News
rocherooflr

FDA awards Roche priority review in HER2-positive breast cancer

October 2, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical

Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …

News
shutterstock_138095450

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017
Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …

News
ablynx_building_web

Ablynx posts strong data on key drug, looks set for approval

October 2, 2017
Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …

News
lilly_logo_2

Lilly reveals major senior leadership reshuffle

October 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …

Appointment
merck_incweb

MSD pulls out of hep C space to Gilead’s relief

October 2, 2017
Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical

MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …

News
gilead_senior_management

Gilead’s COO retires, shares take a dive

September 29, 2017
Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical

Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …

News
fda2outsideweb

Makers of immediate-release opioids must fund training on their use, FDA says

September 29, 2017
Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin

As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …

News
lilly2_web

Lilly receives FDA breast cancer pill approval, doubts remain

September 29, 2017
Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical

Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026